With a proven track record in private equity, the fund manager has successfully completed over 30 deals across technology and healthcare sectors. Active in both North America and Europe, they specialize in growth-stage investments. Their operator-first approach has led to notable exits, including a high-profile sale in the biotech space, showcasing their ability to drive value creation through hands-on management. The manager's data-driven strategy further enhances their decision-making process, focusing on emerging trends and market dynamics.